Table 2.
Demographic and clinical characteristics of children (aged 18 months – < 15 years) living with HIV enrolled under IHC Program between Jan 2005 – June 2016 (N = 2736).
| Patient’s characteristics | Number | (%) |
|---|---|---|
| Gender | ||
| male | 1450 | (53) |
| female | 1286 | (47) |
| Age¶ | ||
| 18 months to < 5 years | 814 | (29) |
| 5 years to < 10 years | 1197 | (44) |
| 10 years to < 15 years | 725 | (27) |
| Growth*¶ | ||
| Normal | 423 | (15) |
| Underweight (<-2 Z-score) | 2079 | (76) |
| Overweight (> 2 Z-score) | 102 | (4) |
| Unknown | 132 | (5) |
| Haemoglobin ¶ | ||
| No anaemia | 551 | (20) |
| Mild anaemia | 442 | (16) |
| Moderate anaemia | 1258 | (46) |
| Severe anaemia | 214 | (8) |
| Unknown | 271 | (10) |
| WHO clinical stage ¶ | ||
| Stage 1 | 697 | (25) |
| Stage 2 | 596 | (22) |
| Stage 3 | 1232 | (45) |
| Stage 4 | 185 | (7) |
| Unknown | 26 | (1) |
| Immunological staging (CD4 count/cd4%)¶ | ||
| No | 661 | (24) |
| Mild | 311 | (12) |
| Advance | 417 | (15) |
| Severe | 995 | (36) |
| Unknown | 352 | (13) |
| Hepatitis B infection ¶ | ||
| Positive | 66 | (3) |
| Negative | 2500 | (91) |
| Unknown | 170 | (6) |
| TB history during follow-up | ||
| Present | 823 | (30) |
| Absent | 1913 | (70) |
*Weight-for-age Z-score or BMI; ¶ at enrolment; HIV-human immunodeficiency virus; IHC – integrated HIV